February 27, 2020 / 12:28 PM / 5 months ago

BRIEF-Co-Diagnostics Announces $4.2 Million Registered Direct Offering Priced At-The-Market

Feb 27 (Reuters) - Co-Diagnostics Inc:

* CO-DIAGNOSTICS ANNOUNCES $4.2 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET

* CO-DIAGNOSTICS - PURCHASE OF 470,000 SHARES AT PRICE OF $9.00 PER SHARE, IN REGISTERED DIRECT OFFERING PRICED AT-THE-MARKED

* CO-DIAGNOSTICS INC - INTENDS TO USE NET PROCEEDS FROM OFFERING FOR ACQUISITION OF PCR (POLYMERASE CHAIN REACTION) EQUIPMENT

* CO-DIAGNOSTICS - TO USE PROCEEDS FROM OFFERING TO BUY RAW MATERIALS TO USE IN SALE OF TESTS FOR INFECTIOUS DISEASE, INCLUDING CORONAVIRUS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below